Business Description
![NightHawk Biosciences Inc NightHawk Biosciences Inc logo](https://static.gurufocus.com/logos/0C0000A4CU.png?14)
NightHawk Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US42237K4094
Description
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | -0.56 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -9.48 | |||||
Beneish M-Score | 2.7 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.5 | |||||
3-Year EBITDA Growth Rate | 5.3 | |||||
3-Year EPS without NRI Growth Rate | -1.2 | |||||
3-Year FCF Growth Rate | 2.7 | |||||
3-Year Book Growth Rate | -38.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.38 | |||||
Quick Ratio | 0.26 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 140.27 | |||||
Days Sales Outstanding | 11.85 | |||||
Days Payable | 413.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.1 | |||||
Shareholder Yield % | -262.39 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.55 | |||||
Operating Margin % | -380.1 | |||||
Net Margin % | -378.22 | |||||
FCF Margin % | -236.92 | |||||
ROE % | -89.03 | |||||
ROA % | -53.69 | |||||
ROIC % | -60.21 | |||||
ROC (Joel Greenblatt) % | -83.11 | |||||
ROCE % | -68.02 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.08 | |||||
PB Ratio | 0.04 | |||||
Price-to-Tangible-Book | 0.04 | |||||
EV-to-EBIT | -0.47 | |||||
EV-to-EBITDA | -0.6 | |||||
EV-to-Revenue | 1.74 | |||||
EV-to-FCF | -0.73 | |||||
Earnings Yield (Greenblatt) % | -212.77 | |||||
FCF Yield % | -782.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NightHawk Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 9.743 | ||
EPS (TTM) ($) | -1.03 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 6.72917 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 6.72917 - 6.72917 | ||
Shares Outstanding (Mil) | 26.08 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NightHawk Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NightHawk Biosciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
NightHawk Biosciences Inc Frequently Asked Questions
What is NightHawk Biosciences Inc(LTS:0A4E)'s stock price today?
The current price of LTS:0A4E is $6.73. The 52 week high of LTS:0A4E is $6.73 and 52 week low is $6.73.
When is next earnings date of NightHawk Biosciences Inc(LTS:0A4E)?
The next earnings date of NightHawk Biosciences Inc(LTS:0A4E) is 2024-08-14 Est..
Does NightHawk Biosciences Inc(LTS:0A4E) pay dividends? If so, how much?
NightHawk Biosciences Inc(LTS:0A4E) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |